Trial intelligence / Profile preview

Silicone Barrier Spray vs Zinc Oxide Ointment for Incontinence-Associated Dermatitis

NCT07637695Completed

Sponsor
Taoyuan Armed Forces General Hospital
Start
Jan 2023
Primary completion
Nov 2023
Countries
1
01

Overview

Randomised trial in incontinence-associated dermatitis (IAD) (2 arms), sponsored by Taoyuan Armed Forces General Hospital. Primary endpoint: Change in Incontinence-Associated Dermatitis Severity Score at Day 14. Started Jan 2023; status: completed.

02

Conditions

incontinence-associated dermatitis (IAD)

Beyond the preview

Go deeper on NCT07637695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07637695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call